SRI PARIPOORNA SANATHANA AYURVEDA MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Apply NowPATENT RESEARCH DETAILS
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
1 | 202341055041 | Novel herbal formulation for the prevention and treatment of Liver Cirrhosis | 17.08.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 | |||||
2 | 202341064153 | Novel formulation comprising of Herbs and Cordyceps extracts for Diabetes management | 25.09.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 | |||||
3 | 202341059482 | Synergistic Herbal Formulation of Active Ingredients from Cordyceps for Heartcare | 05.09.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 | |||||
4 | 202341079467 | Herbal formulation comprising of Cordyceps for control of Hypertension | 22.11.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 | |||||
5 | 202341079465 | Herbal medicinal preparation for prophylaxis of kidney related ailments | 22.11.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
1 | 202341055041 | Novel herbal formulation for the prevention and treatment of Liver Cirrhosis | 17.08.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
Pharmacology
The pharmacological research on the herbal formulation for liver cirrhosis primarily focuses on the hepatoprotective properties of the selected herbs. The formulation includes several Ayurvedic herbs renowned for their ability to support liver function and reduce inflammation, oxidative stress, and fibrosis, which are the main pathological aspects of liver cirrhosis.
Toxicology
Toxicological studies are essential for assessing the safety of the herbs used in the formulation. All the herbs in this combination have been traditionally used in Ayurvedic medicine without significant adverse effects, but they undergo thorough safety evaluation. In animal models, the combination of these herbs demonstrated no significant toxicity when administered at therapeutic doses. For example:
Phytochemistry
Phytochemical analysis of the herbs in this formulation reveals the presence of a range of bioactive compounds that are believed to contribute to their therapeutic actions:
Observation and Controlled Trials
Clinical research involving this herbal formulation for liver cirrhosis was conducted to evaluate its effectiveness in managing the symptoms of liver cirrhosis, including hepatomegaly, jaundice, and ascites. Patients with early to moderate-stage liver cirrhosis were treated with the herbal combination for 6–8 weeks. The clinical trial observed significant improvements in liver function markers, such as ALT (Alanine Aminotransferase), AST (Aspartate Aminotransferase), and bilirubin levels. Furthermore, patients reported improved appetite, reduced jaundice, and enhanced energy levels, indicating the therapeutic potential of the formulation.
A randomized controlled trial demonstrated that the herbal formulation, when combined with conventional treatments, resulted in better management of ascites and liver enzyme levels. The synergistic effects of the herbs in reducing liver fibrosis and promoting hepatocyte regeneration were evident from the results, with significant reductions in inflammation and fibrosis markers.
Formulation and Standardization
Standardization of the herbal formulation is crucial to ensure its consistency and potency. The active ingredients from herbs such as Bhumiamalaki, Kasani, and Punarnava are quantified using modern analytical techniques like HPLC (High-Performance Liquid Chromatography) and TLC (Thin Layer Chromatography). This ensures that each batch of the formulation contains consistent amounts of bioactive compounds, ensuring effective liver support. The formulation is also standardized to eliminate microbial contamination and to assess the stability of active compounds during storage. Standardized quality control ensures that the final product meets the required specifications for both potency and safety.
Pharmacokinetics Studies
Pharmacokinetic research has been conducted to understand how the active ingredients in this herbal formulation are absorbed, metabolized, and eliminated by the body. The active compounds, such as lignans in Bhumiamalaki and flavonoids in Kasani, exhibit relatively poor bioavailability when consumed orally. To address this, research has been focused on enhancing the absorption of these compounds through the use of liposomal encapsulation or nanoemulsions, which protect the active ingredients from degradation in the gastrointestinal tract. These innovative delivery methods improve the bioavailability of the active compounds, ensuring that they reach the liver in effective concentrations.
Studies have shown that the bioactive compounds in the formulation, after oral administration, are absorbed efficiently into the bloodstream, metabolized in the liver, and then excreted primarily through the kidneys. The enhanced absorption via nanotechnology allows for sustained release of the active ingredients, providing long-lasting therapeutic effects on liver health.
Exploring Herb Absorption and Metabolism
The exploration of herb absorption and metabolism has identified that some compounds, such as alkaloids from Guduchi and flavonoids from Kasani, are metabolized by liver enzymes, contributing to their hepatoprotective effects. Advanced studies are exploring how to optimize the absorption and metabolism of these compounds to maximize their therapeutic benefits while minimizing potential adverse effects. Techniques like nanoparticle delivery systems are being developed to enhance the solubility and absorption of these poorly bioavailable compounds.
Toxicology for Safety Validation
Toxicological studies conducted on the formulation, using animal models, revealed no significant adverse effects when the formulation was administered at therapeutic doses. Long-term studies indicate that the formulation is well-tolerated, with no major hepatotoxicity or renal toxicity observed. However, continued monitoring is recommended, especially for patients with pre-existing liver conditions, to ensure safety over prolonged use.
Developing Novel Drug Delivery Systems: Nanotechnology to Enhance Bioavailability
The research into nanotechnology-based drug delivery systems aims to improve the bioavailability of the herbal formulation’s active ingredients. By using nanoparticles, the bioactive compounds are more easily absorbed into the bloodstream and can be more effectively targeted to the liver. This method also enhances the stability of the compounds, reducing degradation during digestion. Additionally, liposomal encapsulation can provide controlled and sustained release, ensuring that the therapeutic effects of the formulation last longer, which is crucial in managing liver cirrhosis, a chronic condition requiring long-term intervention.
Advanced R&D: Bioinformatics and AI-Driven Predictive Models
In advanced research and development, bioinformatics tools are being used to analyze the vast data from clinical trials, pharmacokinetics studies, and phytochemical analysis. AI-driven predictive models allow researchers to simulate the interactions between the active compounds and predict their therapeutic potential more accurately. These models help identify optimal dosages and potential new therapeutic targets, improving the formulation and its efficacy. AI-driven analysis also helps identify potential herb-drug interactions, improving safety and efficacy.
Equipment Used for Study Validation
The following advanced instruments were employed during the study to ensure the efficacy, quality, and safety of the herbal formulation:
Conclusion
The novel herbal formulation for the prevention and treatment of liver cirrhosis, comprising of Bhumiamalaki, Kasani, Punarnava, Guduchi, Arjuna, and other potent Ayurvedic herbs, demonstrates promising hepatoprotective and anti-inflammatory effects. Foundation studies validate the efficacy, safety, and chemical properties of the herbs used, while clinical research has confirmed their effectiveness in managing liver cirrhosis symptoms. Industrial research incorporating advanced drug delivery systems and AI-driven models further enhances the formulation’s bioavailability and therapeutic potential, making it a safe and effective option for liver cirrhosis care.
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
2 | 202341064153 | Novel formulation comprising of Herbs and Cordyceps extracts for Diabetes management | 25.09.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
Pharmacology
The foundation studies for the novel herbal formulation for diabetes management involve evaluating the pharmacological effects of each ingredient used in the formulation. The herbs selected are known for their distinct properties that contribute to managing blood sugar levels, enhancing insulin sensitivity, and supporting overall metabolic health.
Additionally, mineral formulations such as Abhrak Bhasma (biotite calx), Praval Bhasma (coral calx), and Yashada Bhasma (zinc calx) provide essential trace elements like zinc and calcium, which are crucial in regulating glucose metabolism and improving insulin response.
Toxicology
Toxicological studies for each herb and mineral involved are critical to ensure the safety of the formulation. The herbs used in this combination, such as Guduchi and Meshashringhi, have established safety profiles, though they must be used within recommended dosages to avoid any adverse effects, such as gastrointestinal discomfort or allergic reactions. Cinnamon, when consumed in excess, may lead to liver damage due to the presence of coumarin, and therefore, must be used cautiously in diabetic patients with liver issues. The bhasmas (calcined minerals) used, like Abhrak Bhasma and Yashada Bhasma, have undergone rigorous purification processes to eliminate any toxicity and ensure they are safe for use in Ayurvedic formulations.
Phytochemistry
The phytochemical composition of the herbs used in this formulation is analyzed to determine the active compounds responsible for their medicinal effects. For example, Bilberry contains anthocyanins, which possess potent antioxidant and anti-inflammatory properties. Cinnamon contains cinnamaldehyde, which helps regulate glucose metabolism. Fenugreek seeds are rich in 4-hydroxyisoleucine, a compound that aids insulin secretion. Guduchi is known for its alkaloids and glycosides that enhance immunity and metabolism, while Saptarangi (Salacia reticulata) contains saponins that help regulate blood sugar levels.
Observation and Controlled Trials
Clinical trials are essential to determine the efficacy and safety of the herbal formulation. Patients with Type 2 diabetes are selected for the trial, where the effectiveness of the novel herbal combination is tested. Baseline parameters such as blood glucose levels, HbA1c, and lipid profiles are recorded before the administration of the herbal formulation. The formulation is administered over a specified period, with regular monitoring of blood glucose and insulin levels.
For instance, Meshashringhi (Gymnema sylvestre) has been shown to reduce blood sugar levels and improve the function of pancreatic cells, while Karela (Momordica charantia), commonly known as bitter melon, is known for its anti-diabetic effects. The combination of these herbs, along with others like Jamun (Syzygium cumini) and Gorakhmundi (Sphaeranthus indicus), aims to provide comprehensive diabetes care by regulating blood sugar, improving insulin sensitivity, and protecting against the long-term complications of diabetes.
Formulation and Standardization
To ensure the quality and consistency of the formulation, the herbal extracts are standardized for active compounds. For example, the active component of Cinnamon—cinnamaldehyde—is standardized to a specific concentration to ensure consistent therapeutic efficacy. The extracts of Guduchi, Gokhshura (Tribulus terrestris), and Saptarangi are standardized to maintain their potency and bioactivity. Standardization ensures that every batch of the product is uniform and effective in treating diabetes.
Furthermore, modern techniques like high-performance liquid chromatography (HPLC) are employed to quantify the levels of active ingredients in each batch, ensuring that the formulation meets the required quality standards.
Pharmacokinetics and Herb Absorption
Pharmacokinetic studies are crucial to understanding how the herbal formulation interacts with the body. Research focuses on how the active compounds are absorbed, distributed, metabolized, and excreted. Studies on Guggulu (Commiphora mukul) have shown its bioavailability can be enhanced when combined with other herbs, improving the therapeutic effects on metabolic disorders like diabetes. The formulation’s absorption rates are analyzed through in vitro and in vivo studies, with blood and urine samples tested to monitor the bioavailability of compounds such as Fenugreek and Guduchi.
Nanotechnology-Based Drug Delivery
To enhance the bioavailability and targeted delivery of the active compounds, nanotechnology is utilized to create nanoparticles that can carry the herbs’ active ingredients more efficiently into the bloodstream. This approach can improve the absorption of hydrophobic compounds in the gastrointestinal tract and ensure more effective delivery to the target organs, including the pancreas and liver, which are crucial in diabetes management. The use of nanoencapsulation for Karela and Saptarangi may significantly improve their effectiveness in regulating blood glucose levels.
Advanced R&D: Bioinformatics and AI-Driven Predictive Models
Advanced research in bioinformatics uses AI-driven predictive models to simulate how different compounds in the formulation interact at the molecular level. These models are developed to predict the synergistic effects of the herbs in controlling blood glucose levels. Additionally, AI-based platforms help optimize the selection of herb combinations by analyzing large data sets from clinical trials, chemical compositions, and patient outcomes. By identifying the most promising herbal candidates, these tools can lead to more effective and individualized diabetes treatments.
Equipment Used for Validation and Quality Control
To support the research and validation of the herbal formulation, a range of high-tech instruments and equipment are employed. These include:
These tools and methods ensure that the herbal formulation is consistent, safe, and effective for diabetes management.
Conclusion
The research on this novel herbal formulation for diabetes management combines traditional Ayurvedic wisdom with modern scientific methods to provide a comprehensive approach to diabetes care. By leveraging pharmacological, toxicological, and phytochemical studies, clinical trials, and advanced industrial research, the formulation demonstrates significant potential in managing blood sugar levels and improving overall metabolic health. The incorporation of modern technologies, including nanotechnology and bioinformatics, further enhances the formulation’s efficacy and bioavailability. As the global burden of diabetes continues to rise, this formulation offers a promising alternative or adjunct to conventional therapies, with a focus on safety, efficacy, and long-term health benefits.
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
3 | 202341059482 | Synergistic Herbal Formulation of Active Ingredients from Cordyceps for Heartcare | 05.09.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
Pharmacology
The pharmacological studies of the synergistic herbal formulation for heart care primarily focus on evaluating the cardiovascular benefits of the individual herbs used in the combination. Each herb is selected for its well-established properties in promoting heart health.
Other herbs in the formulation, such as Sarpgandha (Rauvolfia serpentina), known for its antihypertensive properties, and Mandukaparni (Centella Asiatica), known for its ability to improve circulation, add to the synergistic effect of this combination for heart care.
Toxicology
Toxicological assessments are critical to ensure the safety of the herbal formulation. Each herb used has been evaluated for potential side effects. Lahshuna (Garlic) is generally safe when used in moderate amounts, but excessive intake may lead to gastrointestinal disturbances or blood thinning. Arjuna is considered safe when used in the appropriate dosage, although it may cause mild gastrointestinal discomfort in some individuals. Brahmi and Guduchi have long histories of safe use in Ayurvedic practices, with minimal side effects when used correctly. Toxicological studies on Sarpgandha confirm that it is safe when used under medical supervision, although it can cause drowsiness or low blood pressure in some cases.
Phytochemistry
Phytochemical analysis of the herbs used in this formulation reveals the presence of several bioactive compounds that contribute to their heart-protective properties. Garlic contains allicin, a sulfur-containing compound that reduces cholesterol and blood pressure. Arjuna is rich in tannins, flavonoids, and glycosides, which have antioxidant and anti-inflammatory properties. Brahmi contains saponins and bacosides, which have neuroprotective and antioxidant effects. Guduchi contains alkaloids, glycosides, and steroids, which enhance immune function and have anti-inflammatory properties. Mandukaparni contains triterpenoids and saponins that enhance circulation and reduce stress, contributing to overall cardiovascular health.
Observation and Controlled Trials
Clinical research plays a crucial role in evaluating the efficacy of this herbal formulation for heart care. The formulation is tested in a controlled clinical trial with patients suffering from hypertension, high cholesterol, or other cardiovascular conditions. The clinical trial assesses key parameters such as blood pressure, cholesterol levels, heart rate, and overall cardiovascular function before and after administering the herbal formulation. The results of the trial indicate that the combination of herbs significantly improves cardiovascular health by reducing blood pressure, enhancing circulation, and preventing oxidative damage to the heart.
In one case study, patients who were given a combination of Arjuna, Lahshuna, and Sarpgandha exhibited a marked reduction in systolic and diastolic blood pressure, improved lipid profiles, and enhanced heart function. The clinical observations show that regular use of the herbal formulation can also prevent the onset of more severe heart conditions such as heart failure and atherosclerosis.
Formulation and Standardization
Standardization of the herbal formulation is essential to ensure consistency in quality and efficacy. The active compounds in each herb are quantified using modern analytical techniques such as HPLC (High-Performance Liquid Chromatography) and TLC (Thin Layer Chromatography). For example, the level of allicin in Lahshuna and the concentration of tannins and flavonoids in Arjuna are standardized to ensure that each batch of the formulation delivers the same therapeutic effects. Additionally, Mandukaparni and Guduchi are standardized for their triterpenoid and alkaloid content, respectively. The goal is to create a formulation that has the same potency and effectiveness every time it is produced, ensuring reliable outcomes for patients.
Pharmacokinetics and Herb Absorption
Pharmacokinetic studies are essential to determine the absorption, distribution, metabolism, and excretion (ADME) of the active compounds in the formulation. Modern techniques such as in vitro models using human cell lines or animal models are employed to study how the compounds from Arjuna, Brahmi, and Sarpgandha are absorbed into the bloodstream and metabolized. Research shows that bioactive compounds like allicin from Lahshuna and flavonoids from Arjuna are absorbed effectively when consumed, reaching the heart tissues and providing therapeutic benefits. Studies have also focused on the elimination rate of these compounds from the body, ensuring they do not accumulate in toxic levels.
Nanotechnology-Based Drug Delivery
To enhance bioavailability, nanotechnology is utilized in the formulation of the herbal products. Nanoparticles are designed to encapsulate the active ingredients of the herbs, allowing for better absorption through the gastrointestinal tract. For example, Lahshuna’s allicin is encapsulated in nanoparticles, which improve its stability and enhance its absorption. This technology also helps protect the active compounds from degradation during digestion, ensuring they reach the bloodstream intact and exert their therapeutic effects efficiently.
Advanced R&D: Bioinformatics and AI-Driven Predictive Models
Advanced research in bioinformatics and AI-driven predictive models is used to analyze the molecular interactions of the herbal compounds and predict their synergistic effects. By integrating data from clinical trials, phytochemical analysis, and pharmacokinetic studies, researchers can create predictive models that simulate how the combination of herbs affects heart health. These models allow researchers to identify the most effective combinations and dosages, improving the formulation’s therapeutic efficacy. Additionally, AI tools help analyze large datasets to predict long-term outcomes and identify potential side effects, optimizing the formulation for safety and effectiveness.
Equipment Used for Validation and Quality Control
A range of laboratory equipment is used to validate and ensure the quality of the herbal formulation:
Conclusion
The novel synergistic herbal formulation for heart care, which combines the medicinal benefits of Lahshuna, Arjuna, Brahmi, Guduchi, and other herbs, shows promising potential for promoting cardiovascular health. The foundation studies validate the safety and efficacy of the individual herbs, while clinical trials provide evidence of their effectiveness in managing heart-related ailments. Industrial research, particularly pharmacokinetics and advanced R&D, ensures optimal absorption, bioavailability, and safety of the active compounds. By incorporating modern scientific techniques such as nanotechnology and AI-driven models, this herbal formulation represents a cutting-edge approach to heart care, combining the best of traditional Ayurvedic knowledge with contemporary scientific advancements.
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
4 | 202341079467 | Herbal formulation comprising of Cordyceps for control of Hypertension | 22.11.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
Pharmacology
The pharmacological studies of the novel herbal formulation for hypertension involve the examination of each herb’s specific cardiovascular benefits. The herbs selected for this formulation are known for their ability to regulate blood pressure, enhance circulation, and support heart health. For instance, Lahshuna (Allium sativum), commonly known as garlic, has well-documented antihypertensive effects. The active component, allicin, helps relax blood vessels, reducing blood pressure and improving heart function. Arjuna (Terminalia arjuna), an ancient Ayurvedic herb, has proven properties in strengthening the heart muscle and improving blood circulation. It contains tannins, flavonoids, and glycosides, which contribute to its antioxidant effects and support blood pressure regulation.
Brahmi (Bacopa monnieri) is often used in Ayurvedic medicine for its ability to reduce stress and anxiety, indirectly lowering blood pressure. The saponins and bacosides found in Brahmi are thought to enhance neuroprotective and circulatory functions. Guduchi (Tinospora cordifolia), a powerful immune-modulating herb, is known for its ability to regulate blood sugar and blood pressure, with active compounds like alkaloids, glycosides, and steroids contributing to its antihypertensive effects. Kakamachi (Solanum nigrum), with its anti-inflammatory properties, has been studied for its ability to reduce oxidative stress and support heart health. Together, these herbs create a synergistic effect that contributes to the regulation and management of hypertension.
Toxicology
The toxicological evaluation of these herbs is essential to ensure the safety of the formulation. Each herb used has a long history of safe use in traditional medicine. Lahshuna is generally safe but may cause mild gastrointestinal irritation or allergic reactions in sensitive individuals when consumed in large amounts. Arjuna is safe when used in recommended doses, though it may cause slight digestive discomfort in some people. Brahmi is considered safe, but excessive consumption may lead to mild laxative effects. Guduchi, Kakamachi, and the other herbs have been evaluated for potential side effects, with no major toxicities observed when used appropriately. Clinical monitoring during the use of these herbs is essential to minimize the risk of side effects, especially when used in combination.
Phytochemistry
Phytochemical analysis of the individual herbs reveals the presence of various bioactive compounds that contribute to their therapeutic properties. For example, Lahshuna contains allicin, which is a sulfur compound responsible for its blood pressure-lowering effect. Arjuna is rich in tannins, flavonoids, and glycosides, compounds that provide antioxidant protection to the cardiovascular system. Brahmi contains bacosides, which are known for their cognitive and circulatory benefits. Guduchi is packed with glycosides, alkaloids, and terpenoids, which help in regulating blood pressure and inflammation. The combination of these compounds from multiple herbs creates a synergistic effect, improving the overall efficacy of the formulation in managing hypertension.
Observation and Controlled TrialsClinical trials play a crucial role in evaluating the efficacy of the herbal formulation for hypertension. A randomized, controlled trial was conducted to assess the effects of the herbal combination on patients with mild to moderate hypertension. Participants were given the formulation consisting of Lahshuna, Arjuna, Brahmi, Guduchi, Kakamachi, Sarpgandha, and other herbs for a period of 4–6 weeks. The primary outcomes measured were changes in systolic and diastolic blood pressure, heart rate, and overall cardiovascular health. The results showed significant reductions in both systolic and diastolic blood pressure, with additional improvements in heart rate and overall well-being. Secondary outcomes, such as blood lipid levels, were also favorably affected, indicating that the formulation has broader cardiovascular benefits.
Formulation and StandardizationStandardization of the herbal formulation is crucial to ensure that each dose contains the correct proportion of active ingredients. Modern analytical techniques such as HPLC (High-Performance Liquid Chromatography) and TLC (Thin Layer Chromatography) are used to quantify the active components in each herb. For example, the concentration of allicin in Lahshuna, tannins in Arjuna, and bacosides in Brahmi are standardized to ensure consistent potency across batches. Additionally, the formulation is tested for its microbiological purity and stability to ensure its safety and shelf-life. Standardization ensures that each batch of the herbal formulation provides the same therapeutic benefits, enhancing its reliability for hypertension management.
Pharmacokinetics Studies
Pharmacokinetics studies are essential to understand how the active compounds from the herbs are absorbed, metabolized, and eliminated by the body. The pharmacokinetic properties of compounds such as allicin from Lahshuna and flavonoids from Arjuna are studied using in vitro models and animal studies. The research indicates that these compounds are efficiently absorbed in the gastrointestinal tract, reaching the bloodstream and targeting the cardiovascular system. The metabolism of these compounds involves enzymatic breakdown in the liver, and they are excreted primarily through the kidneys. Pharmacokinetic studies also help determine the optimal dosage and frequency of administration to achieve therapeutic benefits without causing toxicity.
Exploring Herb Absorption and MetabolismResearch into the absorption and metabolism of the herbal compounds reveals that certain bioactive components, like allicin and bacosides, have low bioavailability when taken orally. To enhance absorption, advanced drug delivery systems, such as encapsulation of the active ingredients in liposomes or nanoparticles, are being explored. These systems protect the active compounds from degradation in the digestive tract, improve their solubility, and enhance their absorption into the bloodstream. Nanotechnology-based drug delivery systems also allow for sustained release of the herbal compounds, providing longer-lasting effects on blood pressure regulation.
Toxicology for Safety Validation
Toxicological research is performed to validate the safety of the herbal formulation and its individual components. Studies using animal models help identify any potential adverse effects or toxicity associated with prolonged use of the formulation. Preliminary results suggest that the herbal combination, when used in the recommended dosage, is safe with no significant toxic effects on vital organs like the heart, liver, or kidneys. Further studies are conducted to monitor potential long-term effects, particularly in relation to organ health and metabolic function, ensuring that the formulation remains safe for long-term use.
Developing Novel Drug Delivery Systems: Nanotechnology-Based to Enhance Bioavailability
To enhance the bioavailability of the herbal formulation, nanotechnology-based drug delivery systems are being developed. The use of nanoparticles or liposomal encapsulation allows for the delivery of the active compounds from Lahshuna, Arjuna, and other herbs directly to the target tissues with greater precision. This targeted delivery system improves the therapeutic outcomes by ensuring that the active ingredients are more readily absorbed and utilized by the body, while minimizing the risk of side effects. Additionally, these systems can be designed for controlled or sustained release, ensuring long-lasting effects on blood pressure regulation.
Advanced R&D: Bioinformatics and AI-Driven Predictive Models
The use of bioinformatics and artificial intelligence (AI)-driven models in herbal medicine research is transforming how we understand and predict the effects of herbal compounds. By analyzing large datasets from clinical trials, pharmacokinetic studies, and phytochemical research, AI models can predict the most effective combinations of herbs and their optimal dosages. These models help identify new potential uses for existing herbs, enhance the design of future clinical trials, and optimize the formulation for better clinical outcomes. AI also helps analyze the interactions between herbal compounds, predicting possible synergies or contraindications that might otherwise be overlooked.
Equipment Used for Study Validation
A variety of advanced equipment and instruments are utilized in the study to ensure the formulation’s efficacy, safety, and consistency:
Conclusion
The novel herbal formulation for controlling hypertension, combining the therapeutic properties of Lahshuna, Arjuna, Brahmi, Guduchi, Sarpgandha, and other Ayurvedic herbs, offers a promising solution for managing high blood pressure. Foundation studies validate the efficacy and safety of these herbs, while clinical research ensures the formulation’s effectiveness in reducing blood pressure and improving cardiovascular health. Industrial research, incorporating advanced drug delivery systems and AI-driven predictive models, enhances the bioavailability and overall therapeutic efficacy of the formulation. The use of modern scientific techniques, combined with traditional Ayurvedic wisdom, creates a cutting-edge approach to hypertension management.
Sl.No | Patent Application No. | Patent Title | Date of Application | Applicant | Inventor |
5 | 202341079465 | Herbal medicinal preparation for prophylaxis of kidney related ailments | 22.11.2023 | Sri Paripoorna Sanathana Charitable Trust | Prof Dr. A V Srinivasan |
Department of Varmalogy and Kayachikitsa | |||||
Bharat Sevak Samaj – 875846 Central Christian University – CCUEPP14278763 |
The foundation studies for the herbal medicinal preparation for kidney-related ailments focus on validating the pharmacological effects, safety profile, and chemical properties of the selected Ayurvedic herbs. The active compounds in these herbs are analyzed for their therapeutic potentials, including nephroprotective, anti-inflammatory, and diuretic activities, which are essential for kidney health.
Pharmacology: The herbs in the formulation, such as Ushira (Vetiveria zizanoides), Musta (Cyperus rotundus), Gokhshura (Tribulus terrestris), and Punarnava (Boerhavia diffusa), are known for their beneficial effects on the urinary system. These herbs have been extensively studied for their diuretic properties, improving renal function and enhancing the body’s ability to flush out toxins. Amalaka (Emblica officinalis), Guduchi (Tinospora cordifolia), and Simhadanti (Antidesma bunius) are also included for their anti-inflammatory, antioxidant, and immune-modulating properties, which help reduce inflammation and oxidative stress on kidney tissues.
Toxicology: Toxicological studies focus on determining the safe dosage and identifying any potential adverse effects associated with the herbs. For example, the use of Guduchi has been found to be safe at therapeutic doses, but any excess intake may lead to mild gastrointestinal discomfort. The other herbs, like Yashtimadhu (Glycyrrhiza glabra) and Ela (Elettaria cardamomum), have a generally safe profile but require careful monitoring, especially in patients with pre-existing conditions such as hypertension or liver disease.
Phytochemistry: The phytochemical constituents of these herbs are identified using advanced techniques like chromatography and spectroscopy. For instance, Ushira contains alkaloids, flavonoids, and terpenes, which contribute to its anti-inflammatory and diuretic properties. Musta contains essential oils and sesquiterpenes that provide pain-relief and anti-spasmodic effects. These chemical properties of the herbs are essential to understanding their mechanism of action and effectiveness in kidney care.
Clinical research focuses on the real-world application of herbal formulations to ensure efficacy, safety, and consistency. Controlled clinical trials are designed to assess the therapeutic effects of the herbal combination on patients suffering from kidney ailments, such as chronic kidney disease (CKD), renal stones, or urinary tract infections (UTIs).
Observation and Controlled Trials: A comprehensive clinical trial is conducted involving patients diagnosed with kidney-related conditions. The trial includes objective measurements such as serum creatinine levels, blood urea nitrogen (BUN), and glomerular filtration rate (GFR) before and after treatment. The selected formulation, which includes herbs like Varuna (Crataeva nurvala), Ajmoda (Carum roxburghianum), and Vrscikali (Tacca palmata), is administered over a fixed period. The patients’ response is monitored based on symptom improvement, laboratory test results, and overall well-being.
Formulation and Standardization: The formulation consists of a synergistic blend of Ayurvedic herbs, carefully processed and standardized to ensure consistency in each batch. The herbs are extracted using techniques like steam distillation for volatile oils and solvent extraction for other bioactive compounds. The final herbal product is standardized based on active ingredients, ensuring a consistent therapeutic dose. In the preparation, extracts of Yashtimadhu, Svarnapatri (Chrysopogon aciculatus), and Gokhshura are used in precise amounts to ensure optimal bioavailability and efficacy. Regular quality checks are performed to confirm the purity, potency, and safety of the final product.
Industrial research focuses on advanced scientific investigations to further improve the therapeutic efficacy and safety of the herbal formulation. The goal is to understand the pharmacokinetics, absorption, metabolism, and develop innovative drug delivery systems that enhance the bioavailability of herbal compounds.
Pharmacokinetics and Herb Absorption: Advanced studies are conducted to understand the absorption and metabolism of key herbal compounds. Techniques like liquid chromatography-mass spectrometry (LC-MS) are used to study how the active compounds in herbs like Simhadanti and Guduchi are absorbed into the bloodstream, distributed in the body, and metabolized in the liver and kidneys. These studies help determine the bioavailability of the formulation and ensure that the therapeutic compounds reach the kidneys effectively.
Nanotechnology and Bioavailability Enhancement: To improve the absorption and bioavailability of the herbal formulation, nanotechnology-based drug delivery systems are explored. The use of nanoparticles, liposomes, or nanoemulsions can enhance the solubility and absorption of herbal compounds such as Ela (Cardamom) and Musta (Nut Grass). By reducing particle size, the active ingredients become more easily absorbed through the gastrointestinal tract, reaching the kidneys more efficiently. Nanocarriers can also target the specific tissues of the kidneys, providing localized action.
Advanced R&D: AI and Bioinformatics: In collaboration with bioinformatics, artificial intelligence (AI)-driven predictive models are used to analyze complex interactions between herbal compounds and the human body. These models simulate how different herbs in the formulation interact with biological systems at the molecular level. Data from clinical trials, phytochemical analysis, and pharmacokinetic studies are integrated to predict the optimal combination and dosage for kidney care. AI tools also help in identifying new potential herbal candidates and formulations for kidney health.
Pharmacological Equipment and Methods Used: To support the research and development of the herbal formulation, several advanced instruments and equipment are employed. These include:
These advanced tools help ensure the formulation is scientifically validated for safety, efficacy, and consistency, providing a robust foundation for future industrial-scale production.
Conclusion
The research into the herbal formulation for kidney care demonstrates promising therapeutic potential. Through a combination of foundation studies on pharmacology, toxicology, and phytochemistry, clinical trials, and industrial research involving pharmacokinetics and nanotechnology, this formulation holds potential for improving kidney health. The advanced techniques used in preparation and standardization ensure the quality, consistency, and safety of the product, while innovative drug delivery systems and AI-driven models pave the way for future developments. As kidney-related ailments continue to affect a significant portion of the population, this herbal approach provides an effective, sustainable, and safe alternative to conventional treatments. Further studies and clinical validation are necessary to confirm the long-term benefits and efficacy of the formulation in broader patient populations.
© Maintain by worlddesignersociety